Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
12mg (week 17+): Despite being the highest dose, many researchers report that the transition from 8mg to 12mg produces fewer new side effects than the jump to 8mg
Advocacy efforts pushing for broader inclusion in trials
As GLP-1s have moved towards weekly dosing, users are less likely to experience the desensitisation that comes from repeated exposure
Developed by Eli Lilly, retatrutide has been evaluated in Phase 2 clinical trials publishing some of the largest reported weight-reduction figures of any incretin-based compound to date, attributed to the added glucagon-receptor component, which is believed to increase energy expenditure alongside the appetite-suppressing and glycemic effects shared with GLP-1/GIP agonism
Valid for 12 months since the production date
Relationship between vitamin D deficiency, bone remodelling and iron status in iron-deficient young women consuming an iron-fortified food
US$ 24.73
US$ 28.79
US$ 21.60
US$ 28.71
US$ 26.62
US$ 21.91
US$ 25.04
